Clinical Trial Update: Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the use of Qutenza (capsaicin patch) for neuropathic pain in patients with head and neck cancer in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED